305 related articles for article (PubMed ID: 9880042)
1. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528
[TBL] [Abstract][Full Text] [Related]
3. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
4. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
5. Variability of beta-amyloid protein deposited lesions in Down's syndrome brains.
Ikeda S; Tokuda T; Yanagisawa N; Kametani F; Ohshima T; Allsop D
Tohoku J Exp Med; 1994 Nov; 174(3):189-98. PubMed ID: 7761984
[TBL] [Abstract][Full Text] [Related]
6. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.
Mrak RE; Griffinbc WS
Neurobiol Aging; 2001; 22(6):915-22. PubMed ID: 11754999
[TBL] [Abstract][Full Text] [Related]
7. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
8. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
Mrak RE; Sheng JG; Griffin WS
J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
[TBL] [Abstract][Full Text] [Related]
9. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and Down's syndrome.
Mann DM
Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.
Sheng JG; Mrak RE; Bales KR; Cordell B; Paul SM; Jones RA; Woodward S; Zhou XQ; McGinness JM; Griffin WS
J Neurochem; 2000 Jan; 74(1):295-301. PubMed ID: 10617132
[TBL] [Abstract][Full Text] [Related]
12. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
Mann DM; Yates PO; Marcyniuk B; Ravindra CR
J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
[TBL] [Abstract][Full Text] [Related]
13. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease.
Murphy GM; Ellis WG; Lee YL; Stultz KE; Shrivastava R; Tinklenberg JR; Eng LF
Prog Brain Res; 1992; 94():475-83. PubMed ID: 1287731
[No Abstract] [Full Text] [Related]
15. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome.
Whitaker-Azmitia PM; Wingate M; Borella A; Gerlai R; Roder J; Azmitia EC
Brain Res; 1997 Nov; 776(1-2):51-60. PubMed ID: 9439795
[TBL] [Abstract][Full Text] [Related]
17. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
Busciglio J; Pelsman A; Wong C; Pigino G; Yuan M; Mori H; Yankner BA
Neuron; 2002 Feb; 33(5):677-88. PubMed ID: 11879646
[TBL] [Abstract][Full Text] [Related]
18. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
19. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.
Glenner GG; Wong CW
Biochem Biophys Res Commun; 1984 Aug; 122(3):1131-5. PubMed ID: 6236805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
